Edinburgh Molecular Imaging are part of a EPSRC funded consortium

19 Sep 2016 | Collaborations, Press Releases

Edinburgh Molecular Imaging is part of an EPSRC funded consortium, led by Dr Jon Shephard of Heriot-Watt University in collaboration with Professor David Jayne from the University of Leeds to develop a revolutionary new bowel cancer surgery tool that will enable...

EM Imaging at EIE16

23 May 2016 | Events

On 12th May, EM Imaging took part to the EIE16 investor showcase (http://www.eie-invest.com/), along with 60 companies across the Life Sciences, Energy and ICT sectors. With more than 900 guests, the event was an absolute success. EM Imaging had the opportunity to...

Edinburgh Molecular Imaging and Mauna Kea Technologies Announce Clinical Molecular Imaging Collaboration

7 Apr 2016 | Collaborations, Press Releases

Edinburgh and Paris, April 6th, 2016 – Edinburgh Molecular Imaging Ltd (EM Imaging) and Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) today announced a clinical research collaboration to study the potential of combining EM Imaging’s in vivo optical...

Edinburgh Molecular imaging Ltd awarded Innovate UK grant to qualify the role of EMI-137 in colorectal cancer lesion detection

9 Mar 2016 | Collaborations, EMI-137

Edinburgh Molecular imaging Ltd (EM Imaging) announced today that the company has received a SBRI Stratified Medicine Connecting the UK Infrastructure Phase I grant from the UK’s innovation agency, Innovate UK. The SBRI grant aims to accelerate and increase the...

EM Imaging finalist at Pitch@Palace

26 Feb 2016 | Awards, Events

EM Imaging has been selected  as one of the 14 teams that will Pitch on Monday 7th March, 2016 at St. James’s Palace. In addition, there will be a Peoples Choice vote and we would appreciate if our followers could vote for us at the...

Edinburgh Molecular Imaging to Pitch@Palace

21 Feb 2016 | Events

Edinburgh Molecular Imaging have been announced as finalists at the Duke of York’s ‘Pitch at the Palace’ competition, which is designed to help entrepreneurs develop their business ideas. The team  will pitch to HRH Duke of York and 300...

EM Imaging obtains global licence for optical agent that detects cancer early

16 Sep 2015 | Press Releases

Edinburgh, United Kingdom, 16 th September, 2015 – Edinburgh Molecular Imaging Ltd. (EM Imaging) has signed an exclusive global license for a novel optical imaging agent that could improve the detection of early-stage colorectal (bowel) cancer. EM Imaging, a...

Edinburgh Molecular Imaging Ltd appoints new Chairman

2 Sep 2015 | Press Releases

Edinburgh, United Kingdom, 2nd September 2015 – The Board of Edinburgh Molecular Imaging Ltd (EM Imaging) is pleased to announce the appointment of John Jeans CBE CEng as non-executive Chairman with effect from 31st August 2015. In an industrial career spanning...

Highly specific, multi-branched fluorescent reporters for analysis of human neutrophil elastase

17 Aug 2015 | Misc

Human neutrophil elastase (HNE) is a serine protease implicated in the pathogenesis of acute and chronic inflammatory disease. Here a series of, internally quenched, single fluorophore fluorescent reporters were synthesised that allowed the rapid, highly...

EM Imaging new chemist recruit starts on Smart: Scotland grant funded breast cancer surgery project

5 Feb 2015 | Misc